Clinical Trials Browser

Phase 2 × Agnosia × Surveys and Questionnaires × Clear all

NCT02514252 2021-05-18

Sublingual Fentanyl for the Management of Breakthrough Pain

Phase 2 Terminated

6 enrolled 8 charts

Agnosia, Neoplasm Metastasis, Recurrence